Anticoagulation in Critically Ill Adults during Extracorporeal Circulation

被引:11
作者
Buchtele, Nina [1 ]
Staudinger, Thomas [1 ]
Schaefer, Anne-Kristin [2 ]
Boegl, Magdalena Sophie [3 ]
Schoergenhofer, Christian [4 ]
Schwameis, Michael [3 ]
机构
[1] Med Univ Vienna, Dept Med 1, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Surg, Div Cardiac Surg, Vienna, Austria
[3] Med Univ Vienna, Dept Emergency Med, Vienna, Austria
[4] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
来源
HAMOSTASEOLOGIE | 2021年 / 41卷 / 04期
关键词
anticoagulants; blood coagulation tests; continuous renal replacement therapy; extracorporeal membrane oxygenation; heart-assist devices; VENTRICULAR ASSIST DEVICE; MOLECULAR-WEIGHT HEPARIN; MEMBRANE-OXYGENATION; UNFRACTIONATED HEPARIN; CLOTTING TIME; LIFE-SUPPORT; BIVALIRUDIN; SAFETY; HEMODIALYSIS; MANAGEMENT;
D O I
10.1055/a-1389-8216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extracorporeal circuits including renal replacement therapy, extracorporealmembrane oxygenation, and ventricular assist devices are increasingly used in critically ill patients. The need for anticoagulation to provide circuit patency and avoid thrombosis remains a challenging task for treating physicians. In the presence of overall low scientific evidence concerning the optimal anticoagulants, monitoring tests, and therapeutic target ranges, recommendations are largely expert opinions and most centers use individual " in-house" anticoagulation protocols. This review gives a practical view on current concepts of anticoagulation strategies in patients with extracorporeal assist devices.
引用
收藏
页码:294 / 306
页数:13
相关论文
共 46 条
[1]   Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial [J].
Andreas, Martin ;
Moayedifar, Roxana ;
Wieselthaler, Georg ;
Wolzt, Michael ;
Riebandt, Julia ;
Haberl, Thomas ;
Angleitner, Philipp ;
Schloeglhofer, Thomas ;
Wiedemann, Dominik ;
Schima, Heinrich ;
Laufer, Guenther ;
Zimpfer, Daniel .
CIRCULATION-HEART FAILURE, 2017, 10 (05)
[2]   Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients [J].
Atallah, S. ;
Liebl, M. ;
Fitousis, K. ;
Bostan, F. ;
Masud, F. .
PERFUSION-UK, 2014, 29 (05) :456-461
[3]   A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients with Heparin Resistance [J].
Bachler, Mirjam ;
Hell, Tobias ;
Boesch, Johannes ;
Treml, Benedikt ;
Schenk, Bettina ;
Treichl, Benjamin ;
Friesenecker, Barbara ;
Lorenz, Ingo ;
Stengg, Daniel ;
Hruby, Stefan ;
Wallner, Bernd ;
Oswald, Elgar ;
Stroehle, Mathias ;
Niederwanger, Christian ;
Irsara, Christian ;
Fries, Dietmar .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[4]  
Bagheri Kaivan, 2014, Adv Biomed Res, V3, P53, DOI 10.4103/2277-9175.125798
[5]   Antithrombotic therapy for left ventricular assist devices in adults: a systematic review [J].
Baumann Kreuziger, L. M. ;
Kim, B. ;
Wieselthaler, G. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) :946-955
[6]   Variability in Anticoagulation Management of Patients on Extracorporeal Membrane Oxygenation: An International Survey [J].
Bembea, Melania M. ;
Annich, Gail ;
Rycus, Peter ;
Oldenburg, Gary ;
Berkowitz, Ivor ;
Pronovost, Peter .
PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) :E77-E84
[7]   Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulation [J].
Boyle, Andrew J. ;
Russell, Stuart D. ;
Teuteberg, Jeffrey J. ;
Slaughter, Mark S. ;
Moazami, Nader ;
Pagani, Francis D. ;
Frazier, O. Howard ;
Heatley, Gerald ;
Farrar, David J. ;
John, Ranjit .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (09) :881-887
[8]   Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO [J].
Chlebowski, Meghan M. ;
Baltagi, Sirine ;
Carlson, Mel ;
Levy, Jerrold H. ;
Spinella, Philip C. .
CRITICAL CARE, 2020, 24 (01)
[9]   Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments [J].
Davenport, Andrew .
NEPHROLOGY, 2009, 14 (05) :455-461
[10]   Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay [J].
Delmas, Clement ;
Jacquemin, Aemilia ;
Vardon-Bounes, Fanny ;
Georges, Bernard ;
Guerrero, Felipe ;
Hernandez, Nicolas ;
Marcheix, Bertrand ;
Seguin, Thierry ;
Minville, Vincent ;
Conil, Jean-Marie ;
Silva, Stein .
JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (07) :679-686